Kefaset al. found that miR-326 matches two regions in the 3’-UTR of PKM2 mRNA and that the transfection of the miR-326 precursor decreased both PKM2 3’-UTR-luciferase reporter activity and PKM2 protein levels in glioma cells [7]. Here, PKM is linked to central nervous system cancer.